N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism

UDC.coleccionInvestigación
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicas
UDC.endPage3251
UDC.grupoInvInvestigación en Microbiología (INIBIC)
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruña
UDC.issue6
UDC.journalTitleAntimicrobial Agents and Chemotherapy
UDC.startPage3246
UDC.volume59
dc.contributor.authorRodríguez-Beltrán, Jerónimo
dc.contributor.authorCabot, Gabriel
dc.contributor.authorValencia, Estela Ynés
dc.contributor.authorCostas, Coloma
dc.contributor.authorBou, Germán
dc.contributor.authorOliver, Antonio
dc.contributor.authorBlázquez, Jesús
dc.date.accessioned2026-08-28T10:32:00Z
dc.date.available2026-08-28T10:32:00Z
dc.date.issued2015-05-14
dc.description.abstract[Abstract] The modulating effect of N-acetylcysteine (NAC) on the activity of different antibiotics has been studied in Pseudomonas aeruginosa. Our results demonstrate that, in contrast to previous reports, only the activity of imipenem is clearly affected by NAC. MIC and checkerboard determinations indicate that the NAC-based modulation of imipenem activity is dependent mainly on OprD. SDS-PAGE of outer membrane proteins (OMPs) after NAC treatments demonstrates that NAC does not modify the expression of OprD, suggesting that NAC competitively inhibits the uptake of imipenem through OprD. Similar effects on imipenem activity were obtained with P. aeruginosa clinical isolates. Our results indicate that imipenem-susceptible P. aeruginosa strains become resistant upon simultaneous treatment with NAC and imipenem. Moreover, the generality of the observed effects of NAC on antibiotic activity was assessed with two additional bacterial species, Escherichia coli and Acinetobacter baumannii. Caution should be taken during treatments, as the activity of imipenem may be modified by physiologically attainable concentrations of NAC, particularly during intravenous and nebulized regimes.
dc.description.sponsorshipThis work was supported by the Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, cofinanced by the European Development Regional Fund “A way to achieve Europe” ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD12/0015), and FIS grant PI13/00063. E.Y.V was funded by a postdoctoral fellowship from CNPq-Brazil (CNPq 236914/2012-0).
dc.identifier.citationRodríguez-Beltrán J, Cabot G, Valencia EY, Costas C, Bou G, Oliver A, Blázquez J. N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism. Antimicrob Agents Chemother. 2015;59(6):3246-51.
dc.identifier.doi10.1128/AAC.00017-15
dc.identifier.issn1098-6596
dc.identifier.urihttps://hdl.handle.net/2183/49110
dc.language.isoeng
dc.publisherAmerican Society for Microbiology
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//RD12%2F0015%2F0002/ES/Enfermedades infecciosas/
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//PI13%2F00063/ES/Bases moleculares de la adquisición de resistencia a antibióticos por hipermutación e hiperrecombinación en cepas patógenas y comensales de Escherichia coli. Búsqueda y caracterización de inhibidores naturales de la mutación y recombinación/
dc.relation.urihttps://doi.org/10.1128/AAC.00017-15
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAcetylcysteine
dc.subjectAnti-Bacterial Agents
dc.subjectImipenem
dc.subjectPorins
dc.subjectPseudomonas aeruginosa
dc.titleN-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism
dc.typejournal article
dc.type.hasVersionAM
dspace.entity.typePublication
relation.isAuthorOfPublication909e08d1-6ed1-4b99-9e9e-c64eb72e7dea
relation.isAuthorOfPublication.latestForDiscovery909e08d1-6ed1-4b99-9e9e-c64eb72e7dea

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
RBeltran_N-acetyl_2015.pdf
Size:
612.57 KB
Format:
Adobe Portable Document Format